Literature DB >> 21278033

Looking beyond recurrence: comorbidities in cancer survivors.

Amy Edgington1, Mary Ann Morgan.   

Abstract

Cancer recurrence is a very real concern for cancer survivors. Surveillance for recurrence and vigilance for development of new cancers are top priorities during follow-up visits after active treatment ends. However, the cancer survivor also is at risk for the development of comorbid conditions. These conditions, including obesity, diabetes, dyslipidemia, menopause, decreased bone mass, hypertension, and hypothyroidism, are discussed with their relevance for general health and their relationships to disease-specific cancers. All of these conditions should be routinely addressed as part of the patient's survivorship care when appropriate. The oncology nurse is in a prime position to educate survivors about the risks for these conditions, both through evidence-based practice guidelines specific to each condition and also through the use of a treatment summary and care plan. This article discusses these selected comorbidities and offers strategies for nurses to address them with survivors during follow-up visits. Clinical practice guidelines for comorbidities are included, along with oncology implications and relevance for survivors. Recommendations for modifiable risk factors and healthy living also are included, along with Web sites for survivorship care plans.

Entities:  

Mesh:

Year:  2011        PMID: 21278033     DOI: 10.1188/11.CJON.E3-E12

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  25 in total

1.  The use of cancer treatment summaries and care plans among Massachusetts physicians.

Authors:  Anna Merport; Stephenie C Lemon; Joshua Nyambose; Marianne N Prout
Journal:  Support Care Cancer       Date:  2012-04-14       Impact factor: 3.603

Review 2.  The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review.

Authors:  Sun Hee Rim; Gery P Guy; K Robin Yabroff; Kathleen A McGraw; Donatus U Ekwueme
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2016-10-06       Impact factor: 2.217

3.  High atherogenic index of plasma and cardiovascular risk factors among Ghanaian breast cancer patients.

Authors:  Emmanuel A Tagoe; Eric Dwamena-Akoto; Josephine Nsaful; Anastasia R Aikins; Joe-Nat Clegg-Lamptey; Osbourne Quaye
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-08

4.  Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.

Authors:  Heather P Tarleton; Suzanne Ryan-Ibarra; Marta Induni
Journal:  J Cancer Surviv       Date:  2014-04-09       Impact factor: 4.442

5.  Evaluation of health perceptions and healthcare utilization among population-based female cancer survivors and cancer-free women.

Authors:  Kate E Dibble; Maneet Kaur; Junrui Lyu; Avonne E Connor
Journal:  Cancer Causes Control       Date:  2021-10-06       Impact factor: 2.506

6.  Disparities in healthcare utilization and access by length of cancer survivorship among population-based female cancer survivors.

Authors:  Kate E Dibble; Maneet Kaur; Avonne E Connor
Journal:  J Cancer Surviv       Date:  2021-10-18       Impact factor: 4.062

7.  Breast and prostate cancer survivors in a diabetic cohort: results from the Living with Diabetes Study.

Authors:  Adedayo A Onitilo; Maria Donald; Rachel V Stankowski; Jessica M Engel; Gail Williams; Suhail A R Doi
Journal:  Clin Med Res       Date:  2013-05-13

8.  Association between history of cancer and major adverse cardiovascular events in patients with chest pain presenting to the emergency department: a secondary analysis of a prospective cohort study.

Authors:  Ziad Faramand; Hongjin Li; Nada Al-Rifai; Stephanie O Frisch; Omar Abu-Jaradeh; Ahmad Mahmoud; Salah Al-Zaiti
Journal:  Eur J Emerg Med       Date:  2021-01-01       Impact factor: 4.106

9.  Metabolic syndrome in Mexican women survivors of breast cancer: a pilot study at a general hospital.

Authors:  Carlos Manuel Ortiz-Mendoza; Tania Angélica de-la-Fuente-Vera; Ernesto Pérez-Chávez
Journal:  Med Arch       Date:  2014

10.  A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record.

Authors:  Adedayo A Onitilo; Rachel V Stankowski; Richard L Berg; Jessica M Engel; Gail M Williams; Suhail A Doi
Journal:  BMC Med Inform Decis Mak       Date:  2014-05-09       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.